Century Therapeutics Ownership | Who Owns Century Therapeutics?


OverviewForecastRevenueFinancialsChart

Century Therapeutics Ownership Summary


Century Therapeutics is owned by 15.63% institutional investors, 25.94% insiders, and 58.43% retail investors. Boxer capital is the largest institutional shareholder, holding 7.87% of IPSC shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 1.45% of its assets in Century Therapeutics shares.

IPSC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCentury Therapeutics15.63%25.94%58.43%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Boxer capital4.90M7.87%$12.50M
Blackrock2.90M4.65%$7.38M
Bain capital life sciences investors3.54M4.10%$1.76M
Vanguard group2.10M2.43%$2.09M
Dafna capital management1.70M1.98%$848.71K
Renaissance1.35M1.56%$1.34M
Casdin capital1.23M1.42%$611.64K
Acadian asset management1.22M1.41%$1.21M
Syncona portfolio1.21M1.40%$1.21M
Two sigma investments, lp911.45K1.06%$453.90K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Syncona portfolio1.21M3.52%$1.21M
Boxer capital4.90M0.66%$12.50M
Superstring capital management lp462.96K0.23%$230.56K
Dafna capital management1.70M0.21%$848.71K
Bain capital life sciences investors3.54M0.12%$1.76M
Casdin capital1.23M0.05%$611.64K
Parametrica management27.84K0.04%$27.70K
Gsa capital partners llp333.20K0.03%$331.00K
Tang capital management900.00K0.02%$448.20K
Harbourvest partners29.02K0.01%$14.45K

Top Buyers

HolderShares% AssetsChange
Boxer capital4.90M0.66%3.15M
Blackrock2.90M0.00%1.40M
Acadian asset management1.22M0.00%497.30K
Two sigma advisers, lp857.60K0.00%490.50K
Two sigma investments, lp911.45K0.00%338.90K

Top Sellers

HolderShares% AssetsChange
Vr adviser---2.50M
Bain capital life sciences investors3.54M0.12%-1.87M
Millennium management---1.61M
Adage capital partners gp---1.32M
Renaissance1.35M0.00%-1.24M

New Positions

HolderShares% AssetsChangeValue
Lazard asset management62.95K-62.95K$35.00K
Susquehanna group, llp33.40K-33.40K$33.73K
Abel hall17.58K0.00%17.58K$9.82K
Simplex trading2.40K-2.40K$2.38K
Srs capital advisors99.00-99.00$49.00

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Ifp advisors-6.00
Capital performance advisors llp-12.00
Eversource wealth advisors-28.00
Morgan stanley-118.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202532-39.62%13,517,957-33.34%152.83%12-25.00%9-60.87%
Sep 30, 202551-16.39%20,279,909-7.85%233.59%15-55.88%2321.05%
Jun 30, 202566-4.35%22,628,552-20.19%262.42%3760.87%20-31.03%
Mar 31, 202570-5.41%29,566,395-18.77%341.86%23-48.89%29190.00%
Dec 31, 2024748.82%36,399,688-8.20%421.96%4441.94%10-37.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O1.22M1.45%-96.60K
Syncona Ord1.21M1.43%212.28K
Vanguard Total Stock Mkt Idx Inv1.51M0.84%220.80K
Fidelity Small Cap Index480.13K0.56%-
State St Russell Sm/Mid Cp® Indx SL Cl I366.83K0.43%-
State St Russell Sm/Mid Cp® Indx NL Cl C366.83K0.43%-
Federated Hermes Kaufmann Growth267.75K0.32%-
Federated Hermes Kaufmann R267.75K0.32%-
Vanguard Institutional Extnd Mkt Idx Tr539.66K0.30%-
Vanguard Russell 2000 ETF229.84K0.27%2.12K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 12, 2026Carr Douglas SVP Finance & OperationsSell$17.95K
Mar 12, 2026Russotti Gregory See RemarksSell$25.68K
Mar 09, 2026Russotti Gregory See RemarksSell$1.21K
Feb 03, 2026Carr Douglas SVP Finance & OperationsSell$588.51
Dec 22, 2025Cowan Chad Chief Scientific OfficerBuy$49.25K

Insider Transactions Trends


DateBuySell
2026 Q1-2
2025 Q435
2025 Q3-4
2025 Q2-7
2025 Q1-7

IPSC Ownership FAQ


Who Owns Century Therapeutics?

Century Therapeutics shareholders are primarily institutional investors at 15.63%, followed by 25.94% insiders and 58.43% retail investors. The average institutional ownership in Century Therapeutics's industry, Biotech Stocks , is 381.47%, which Century Therapeutics falls below.

Who owns the most shares of Century Therapeutics?

Century Therapeutics’s largest shareholders are Boxer capital (4.9M shares, 7.87%), Blackrock (2.9M shares, 4.65%), and Bain capital life sciences investors (3.54M shares, 4.10%). Together, they hold 16.62% of Century Therapeutics’s total shares outstanding.

Does Blackrock own Century Therapeutics?

Yes, BlackRock owns 4.65% of Century Therapeutics, totaling 2.9M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.38M$. In the last quarter, BlackRock increased its holdings by 1.4M shares, a 93.28% change.

Who is Century Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Century Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.52% of its assets in 1.21M Century Therapeutics shares, valued at 1.21M$.

Who is the top mutual fund holder of Century Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Century Therapeutics shares, with 1.45% of its total shares outstanding invested in 1.22M Century Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools